Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Complement and Coagulation Cascades WP558,2.9571280481031106e-05,7.703254800490263,80.33498665714178,"['CPB2', 'SERPIND1', 'F10', 'C1R', 'PROS1', 'CFI', 'SERPING1', 'CLU', 'F5']",0.008888207140022884,0,0,9
2,Zinc homeostasis WP3529,3.856055158361338e-05,6.310265166733628,64.13299670955675,"['MT2A', 'MT1A', 'MT1M', 'MT1F', 'MT1G', 'MT1X', 'SLC30A1', 'SLC39A1', 'SLC39A14', 'MT1E']",0.008888207140022884,0,0,10
3,Complement system WP2806,0.00012811321876399592,4.7112839405103015,42.225335369951075,"['LAMA5', 'F10', 'C1R', 'PROS1', 'CFI', 'F11', 'WAS', 'SERPING1', 'CD59', 'LAMB1', 'ICAM1']",0.019686731283400705,0,0,11
4,Nuclear Receptors Meta-Pathway WP2882,0.00038868844429034967,2.118403986620247,16.63525972724275,"['SRXN1', 'AMIGO2', 'IRS2', 'DBI', 'SLC5A3', 'CYP3A5', 'CYP3A7', 'DNAJB1', 'ZIC2', 'HMOX1', 'STOM', 'HES1', 'SLC39A1', 'SLC19A2', 'CBR3', 'NQO1', 'HSP90AA1', 'GPX2', 'SLC10A1', 'GPX3', 'HGF', 'SLC39A14', 'SOD3', 'NFKB2', 'TGFBR3', 'SLC5A9', 'SPINK13', 'ACKR3', 'EPHA2', 'HSPA1A']",0.03704251521168781,0,0,30
5,Osteoblast differentiation WP4787,0.0004202408079619134,2.957389635316699,22.99276591271649,"['FZD1', 'HES6', 'NOTCH3', 'SMAD1', 'FZD5', 'FZD7', 'WNT7B', 'FZD9', 'PIK3R3', 'SMAD9', 'PIK3CD', 'PIK3C2A', 'FGF2', 'GLI2', 'PRKCQ', 'FGFR3']",0.03704251521168781,0,0,16
6,Spinal Cord Injury WP2431,0.000548475300963939,3.0019175455417066,22.53950256640919,"['IL1R1', 'GADD45A', 'BDNF', 'XYLT1', 'PLA2G5', 'TACR1', 'RHOC', 'NTN1', 'AQP1', 'ICAM1', 'GFAP', 'LGALS3', 'GJA1', 'ZFP36', 'VIM']",0.03704251521168781,0,0,15
7,Hematopoietic Stem Cell Differentiation WP2849,0.0005624676930191207,5.318941798941799,39.80258219042059,"['HES6', 'MUC1', 'SPI1', 'CSF1', 'TRIM29', 'PIM1', 'CXCR4', 'NFATC2']",0.03704251521168781,0,0,8
8,Differentiation Pathway WP2848,0.000730264238934146,5.980019029495718,43.188320059685424,"['NT5E', 'CSF1', 'EGF', 'HGF', 'WNT7B', 'FGF2', 'VEGFA']",0.042081476768580164,0,0,7
9,NRF2 pathway WP2884,0.0017652032150382783,2.527123951914335,16.0206756553172,"['NQO1', 'HSP90AA1', 'GPX2', 'SRXN1', 'GPX3', 'HGF', 'SLC5A3', 'SLC39A14', 'SOD3', 'DNAJB1', 'SLC5A9', 'HMOX1', 'SLC39A1', 'EPHA2', 'CBR3', 'HSPA1A']",0.09006225783560001,0,0,16
10,Inflammatory Response Pathway WP453,0.0019536281526160524,11.935483870967742,74.45434859059542,"['LAMA5', 'LAMB2', 'LAMB1', 'TNFRSF1A']",0.09006225783560001,0,0,4
11,Neural Crest Differentiation WP2064,0.0033728992166170563,2.7648183556405352,15.737297980203769,"['NOTCH3', 'SMAD1', 'DCT', 'ZIC1', 'HES1', 'TBX6', 'ETS1', 'FGF2', 'FGFR3', 'HES5', 'GFAP', 'NFKB2']",0.14135513989640572,0,0,12
12,Leptin Insulin Overlap WP3935,0.007625991172081371,6.818650040661426,33.249053428316586,"['SOCS3', 'IRS1', 'PIK3R3', 'IRS2']",0.25743794918034585,0,0,4
13,Blood Clotting Cascade WP272,0.00778341809637911,11.925118483412323,57.90550966919352,"['F10', 'F11', 'F5']",0.25743794918034585,0,0,3
14,Globo Sphingolipid Metabolism WP1424,0.007818072209381435,4.974675530231086,24.133729339098643,"['ST6GAL1', 'ST6GAL2', 'ST8SIA1', 'FUT2', 'A4GALT']",0.25743794918034585,0,0,5
15,"GPCRs, Class A Rhodopsin-like WP455",0.009579801288219328,2.484024436395091,11.545990081825394,"['P2RY12', 'GPR39', 'EDNRA', 'GPR37', 'GPR87', 'CHRM5', 'HTR2B', 'ACKR4', 'CXCR4', 'ACKR3', 'GPR19']",0.29192866497525766,0,0,11
16,Lung fibrosis WP3624,0.01055997381485491,3.771763057834701,17.164103610887274,"['MT2A', 'CEBPB', 'EGF', 'HGF', 'HMOX1', 'FGF2']",0.29192866497525766,0,0,6
17,Glucocorticoid Receptor Pathway WP2880,0.011997775082978522,2.690562440419447,11.900449304136785,"['TGFBR3', 'HSP90AA1', 'ZIC2', 'AMIGO2', 'STOM', 'SPINK13', 'ACKR3', 'SLC19A2', 'NFKB2']",0.29192866497525766,0,0,9
18,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.012840531192778604,8.943127962085308,38.948651325844615,"['SPI1', 'APOE', 'NFKB2']",0.29192866497525766,0,0,3
19,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.012840531192778604,8.943127962085308,38.948651325844615,"['SPI1', 'CSF1', 'ID2']",0.29192866497525766,0,0,3
20,Gene regulatory network modelling somitogenesis  WP2854,0.012840531192778604,8.943127962085308,38.948651325844615,"['LFNG', 'HES1', 'TBX6']",0.29192866497525766,0,0,3
21,Hypertrophy Model WP516,0.014583520204398865,5.302551127978073,22.418460466784083,"['IL1R1', 'IFRD1', 'IL18', 'VEGFA']",0.29192866497525766,0,0,4
22,Breast cancer pathway WP4262,0.014650230202043443,1.9563633514826275,8.262307836293306,"['FZD1', 'NOTCH3', 'FZD5', 'GADD45A', 'EGF', 'FZD7', 'WNT7B', 'FZD9', 'PIK3R3', 'PIK3CD', 'FGF2', 'IGF1R', 'NFKB2', 'SFRP4', 'HES1', 'HES5']",0.29192866497525766,0,0,16
23,ESC Pluripotency Pathways WP3931,0.01482324638789625,2.132044307530969,8.979229599916573,"['FZD1', 'SMAD1', 'FZD5', 'EGF', 'FZD7', 'WNT7B', 'FZD9', 'GAB1', 'SMAD9', 'PIK3CD', 'FGF2', 'SELENOP', 'FGFR3']",0.29192866497525766,0,0,13
24,Striated Muscle Contraction Pathway WP383,0.01613434903676791,3.9787907565685345,16.419692788761672,"['ACTA2', 'TNNT1', 'TCAP', 'VIM', 'TTN']",0.29192866497525766,0,0,5
25,Benzene metabolism WP3891,0.017097774304407717,23.831439393939394,96.9655269872027,"['NQO1', 'EPHX1']",0.29192866497525766,0,0,2
26,Drug Induction of Bile Acid Pathway WP2289,0.017097774304407717,23.831439393939394,96.9655269872027,"['SLC10A1', 'SLC51A']",0.29192866497525766,0,0,2
27,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.017097774304407717,23.831439393939394,96.9655269872027,"['NRP1', 'VEGFA']",0.29192866497525766,0,0,2
28,Differentiation of white and brown adipocyte WP2895,0.019186925522166658,4.771916508538899,18.86589691350086,"['SMAD1', 'CEBPB', 'ZIC1', 'SMAD9']",0.30500595399030445,0,0,4
29,Phytochemical activity on NRF2 transcriptional activation WP3,0.019186925522166658,4.771916508538899,18.86589691350086,"['NQO1', 'CEBPB', 'MAF', 'HMOX1']",0.30500595399030445,0,0,4
30,Alpha 6 Beta 4 signaling pathway WP244,0.021746159252646724,3.1148123656802778,11.924492629670187,"['LAMA5', 'IRS1', 'LAMB2', 'GAB1', 'IRS2', 'LAMB1']",0.32338643275710127,0,0,6
31,Proximal tubule transport WP4917,0.021746159252646724,3.1148123656802778,11.924492629670187,"['SLC13A3', 'SLC22A6', 'SLC1A1', 'SLC3A1', 'SLC4A2', 'AQP1']",0.32338643275710127,0,0,6
32,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.02409937544160053,3.5101390983743923,13.077266653558588,"['HSP90AA1', 'ACAP1', 'IL18', 'ERBIN', 'NOD1']",0.34142360460194104,0,0,5
33,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.02459267866182455,4.337760910815939,16.072733679696455,"['ICAM1', 'NFKB2', 'VEGFA', 'TNFRSF1A']",0.34142360460194104,0,0,4
34,PI3K-Akt signaling pathway WP4172,0.02580263822744569,1.5871735378027731,5.804735711768428,"['LAMA5', 'CSF1', 'IRS1', 'TNC', 'PIK3R3', 'PIK3CD', 'FGF2', 'IGF1R', 'IFNAR2', 'HSP90AA1', 'ANGPT2', 'BDNF', 'EGF', 'LAMB2', 'HGF', 'LAMB1', 'OSMR', 'VEGFA', 'EFNA1', 'CCNE2', 'IL7', 'IL3RA', 'COL6A6', 'FGFR3', 'EPHA2']",0.34142360460194104,0,0,25
35,Copper homeostasis WP3286,0.026696733616238044,2.450793650793651,8.879750007661157,"['STEAP3', 'MT2A', 'MT1A', 'MT1F', 'MT1G', 'MT1X', 'SOD3', 'MT1E']",0.34142360460194104,0,0,8
36,Adipogenesis WP236,0.026910369040500412,1.9444019138755981,7.029486575856544,"['FZD1', 'CEBPB', 'CEBPD', 'IRS1', 'GADD45A', 'IRS2', 'SFRP4', 'SOCS3', 'KLF7', 'KLF6', 'BMP1', 'PNPLA3', 'LPIN3']",0.34142360460194104,0,0,13
37,Transcriptional cascade regulating adipogenesis WP4211,0.027408299245857422,5.961137440758294,21.441671410203394,"['CEBPB', 'CEBPD', 'KLF2']",0.34142360460194104,0,0,3
38,Oxidative Stress WP408,0.028883992580207594,3.314867574126833,11.749441136685167,"['NQO1', 'GPX3', 'HMOX1', 'MT1X', 'SOD3']",0.34142360460194104,0,0,5
39,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.028883992580207594,3.314867574126833,11.749441136685167,"['FZD1', 'BMP1', 'P3H2', 'TNFRSF11B', 'COLGALT1']",0.34142360460194104,0,0,5
40,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.03343715826345695,2.3308710801393726,7.9205038221808115,"['CEBPB', 'MAOB', 'CEBPD', 'WNT7B', 'HMGA2', 'TNFRSF11B', 'HES1', 'HES5']",0.37181101801774136,0,0,8
41,Vitamin D Receptor Pathway WP2877,0.034623028363134314,1.9926774912448264,6.701845190403888,"['CEACAM1', 'IGFBP5', 'BCL6', 'GADD45A', 'S100A6', 'NFATC2', 'PRKCQ', 'TNFRSF11B', 'ATP2C2', 'KLF4', 'CYP3A5']",0.37181101801774136,0,0,11
42,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.035707397145432404,1.5471392025956199,5.155682669638383,"['IFNAR2', 'PFKFB1', 'LAMA5', 'HSP90AA1', 'ANGPT2', 'CSF1', 'CAB39L', 'IRS1', 'EGF', 'LAMB2', 'HGF', 'TNC', 'PIK3CD', 'IRS2', 'LAMB1', 'OSMR', 'PIK3C2A', 'FGF2', 'VEGFA', 'IGF1R', 'EFNA1', 'IL3RA', 'FGFR3', 'EPHA2']",0.37181101801774136,0,0,24
43,Development and heterogeneity of the ILC family WP3893,0.03694029241154956,5.109140148950575,16.8522555269304,"['IL7', 'ID2', 'IL18']",0.37181101801774136,0,0,3
44,Eicosanoid Synthesis WP167,0.03694029241154956,5.109140148950575,16.8522555269304,"['PNPLA3', 'ALOX12', 'PLA2G5']",0.37181101801774136,0,0,3
45,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.03694029241154956,5.109140148950575,16.8522555269304,"['FAM20C', 'FGFR3', 'NFKB2']",0.37181101801774136,0,0,3
46,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.0379069801449758,3.6698292220113853,12.009956549497167,"['TGFBR3', 'ANGPT2', 'FLNA', 'ENG']",0.37181101801774136,0,0,4
47,Transcription factor regulation in adipogenesis WP3599,0.0379069801449758,3.6698292220113853,12.009956549497167,"['CEBPB', 'CEBPD', 'IRS1', 'IRS2']",0.37181101801774136,0,0,4
48,Phosphodiesterases in neuronal function WP4222,0.04096364476510024,2.388011417697431,7.629864401370077,"['PDE10A', 'PDE6C', 'PDE5A', 'ADCY2', 'PDE6B', 'PDE8B', 'GRIN2D']",0.3934216715981502,0,0,7
49,Metapathway biotransformation Phase I and II WP702,0.04478236267259233,1.8393881453154877,5.71303088516155,"['CYP39A1', 'HS3ST3B1', 'CHST9', 'GPX2', 'CHST6', 'HS3ST3A1', 'CHST7', 'GPX3', 'CYP4F3', 'EPHX1', 'CYP3A5', 'CYP3A7']",0.4092072647672628,0,0,12
50,Exercise-induced Circadian Regulation WP410,0.04578647413808598,2.321492758219685,7.158941727735566,"['DNAJA1', 'CEBPB', 'BTG1', 'RBPMS', 'PPP1R3C', 'TAB2', 'ETV6']",0.4092072647672628,0,0,7
51,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.045838791485124465,3.407427487123882,10.50381969463804,"['NQO1', 'SRXN1', 'EPHX1', 'HMOX1']",0.4092072647672628,0,0,4
52,Vitamin A and carotenoid metabolism WP716,0.04664448432813417,2.8406367295256185,8.707121390323714,"['RBP2', 'LRAT', 'BCO1', 'RLBP1', 'RPE65']",0.4092072647672628,0,0,5
53,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.0479331720117835,4.470142180094787,13.58005720661478,"['TNC', 'CXCR4', 'VEGFA']",0.4092072647672628,0,0,3
54,NOTCH1 regulation of endothelial cell calcification WP3413,0.0479331720117835,4.470142180094787,13.58005720661478,"['SAT1', 'FGFR3', 'VEGFA']",0.4092072647672628,0,0,3
55,Wnt signaling in kidney disease WP4150,0.05373154272495847,2.711301044634378,7.927180154154367,"['FZD1', 'FZD5', 'WNT7B', 'FZD7', 'FZD9']",0.434139671104157,0,0,5
56,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.05446308938203951,1.8964316006300739,5.519056054753082,"['MRAS', 'EGF', 'HGF', 'GAB1', 'PIK3CD', 'PIK3R3', 'FGF2', 'FGFR3', 'IGF1R', 'VEGFA']",0.434139671104157,0,0,10
57,Ovarian infertility WP34,0.05462060937969872,3.180012650221379,9.245390718532175,"['CEBPB', 'DMC1', 'MSH5', 'SYNE2']",0.434139671104157,0,0,4
58,Peptide GPCRs WP24,0.05462060937969872,3.180012650221379,9.245390718532175,"['EDNRA', 'GNRHR', 'CXCR4', 'TACR1']",0.434139671104157,0,0,4
59,IL-4 signaling pathway WP395,0.06236644466274974,2.142404059625753,5.944588304533423,"['SOCS3', 'CEBPB', 'IRS1', 'INPP5D', 'PIK3CD', 'FLNA', 'IRS2']",0.4851738975222888,0,0,7
60,Folate Metabolism WP176,0.06314627733478813,2.3095179688458236,6.379584675921373,"['GPX2', 'CSF1', 'GPX3', 'SOD3', 'ICAM1', 'NFKB2']",0.4851738975222888,0,0,6
61,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.06860864842048894,2.0886774500475735,5.596270108626146,"['IL1R1', 'IRAK2', 'MKNK2', 'IRF7', 'TAB2', 'IL1RAP', 'MAP3K14']",0.5095267854143507,0,0,7
62,Neovascularisation processes WP4331,0.06967051363864947,2.4849635960747074,6.619888593068745,"['NOTCH3', 'SMAD1', 'CXCR4', 'SMAD9', 'NFKB2']",0.5095267854143507,0,0,5
63,Ebola Virus Pathway on Host WP4217,0.0716051791294813,1.6869643459678327,4.447829737472203,"['SOCS3', 'ACTN1', 'NEDD4', 'TYRO3', 'IRF7', 'PIK3R3', 'PIK3CD', 'FLNA', 'FLNB', 'RHOC', 'IGF1R', 'NFKB2']",0.5095267854143507,0,0,12
64,Cytokines and Inflammatory Response WP530,0.07308556221515355,5.956439393939394,15.582786668206113,"['CSF1', 'IL7']",0.5095267854143507,0,0,2
65,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.07308556221515355,5.956439393939394,15.582786668206113,"['SOCS3', 'CHI3L1']",0.5095267854143507,0,0,2
66,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.07308556221515355,5.956439393939394,15.582786668206113,"['LFNG', 'TBX6']",0.5095267854143507,0,0,2
67,IL1 and megakaryocytes in obesity WP2865,0.07405269983245445,3.5755450236966824,9.307066033504222,"['IL1R1', 'IL18', 'ICAM1']",0.5095267854143507,0,0,3
68,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.07766719994146634,1.9099428571428572,4.880519475091987,"['FZD1', 'SFRP4', 'FZD5', 'WIF1', 'WNT7B', 'FZD7', 'FZD9', 'KLF4']",0.5226344511623741,0,0,8
69,MAPK Signaling Pathway WP382,0.0782251130807024,1.4443188241944602,3.680362017821077,"['IL1R1', 'GADD45A', 'BDNF', 'EGF', 'HSPB1', 'HSPA2', 'FGF2', 'RASGRP3', 'NFKB2', 'TNFRSF1A', 'MRAS', 'MKNK2', 'FLNA', 'FLNB', 'TAB2', 'PTPN7', 'MAP3K6', 'FGFR3', 'MAP3K14', 'HSPA1B', 'HSPA1A']",0.5226344511623741,0,0,21
70,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.082173492099582,1.9888994608309547,4.970105631740034,"['SOCS3', 'NQO1', 'HSPA5', 'HSPB1', 'APOE', 'VIM', 'ETS1']",0.5281759231752896,0,0,7
71,Selenium Micronutrient Network WP15,0.082173492099582,1.9888994608309547,4.970105631740034,"['GPX2', 'GPX3', 'SELENOP', 'DIO2', 'SOD3', 'ICAM1', 'NFKB2']",0.5281759231752896,0,0,7
72,NRF2-ARE regulation WP4357,0.0859272877972684,2.6493780307822052,6.502246182044824,"['NQO1', 'CEBPB', 'MAF', 'HMOX1']",0.5281759231752896,0,0,4
73,Type II interferon signaling (IFNG) WP619,0.0859272877972684,2.6493780307822052,6.502246182044824,"['SOCS3', 'SPI1', 'ICAM1', 'PSMB9']",0.5281759231752896,0,0,4
74,Endochondral Ossification with Skeletal Dysplasias WP4808,0.08592883782678247,2.1052337284723777,5.1667399677824335,"['COL10A1', 'FGF2', 'SLC38A2', 'FGFR3', 'IGF1R', 'VEGFA']",0.5281759231752896,0,0,6
75,Endochondral Ossification WP474,0.08592883782678247,2.1052337284723777,5.1667399677824335,"['COL10A1', 'FGF2', 'SLC38A2', 'FGFR3', 'IGF1R', 'VEGFA']",0.5281759231752896,0,0,6
76,The influence of laminopathies on Wnt signaling WP4844,0.08792861517027854,2.2934472934472936,5.575897828718691,"['CEBPB', 'CEBPD', 'HMGA2', 'HES1', 'HES5']",0.5311610028490523,0,0,5
77,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.0890161059552766,3.2502369668246445,7.862121577503648,"['FZD1', 'SFRP4', 'FZD7']",0.5311610028490523,0,0,3
78,Biogenic Amine Synthesis WP550,0.09718360042927951,4.764772727272727,11.107415674621782,"['PNMT', 'PAH']",0.5311610028490523,0,0,2
79,Farnesoid X receptor pathway WP2879,0.09718360042927951,4.764772727272727,11.107415674621782,"['SLC10A1', 'IRS2']",0.5311610028490523,0,0,2
80,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.09718360042927951,4.764772727272727,11.107415674621782,"['HES1', 'VEGFA']",0.5311610028490523,0,0,2
81,Role of Osx and miRNAs in tooth development WP3971,0.09718360042927951,4.764772727272727,11.107415674621782,"['NOTCH3', 'KLF4']",0.5311610028490523,0,0,2
82,Selective expression of chemokine receptors during T-cell polarization WP4494,0.09718360042927951,4.764772727272727,11.107415674621782,"['CXCR4', 'IL12RB2']",0.5311610028490523,0,0,2
83,CAMKK2  Pathway WP4874,0.0979017575423427,2.2083289367239987,5.131694416144414,"['MAF', 'WFS1', 'HMOX1', 'NFATC2', 'ICAM1']",0.5311610028490523,0,0,5
84,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.0979017575423427,2.2083289367239987,5.131694416144414,"['IGFBP5', 'IRS1', 'FBXO32', 'IGF1R', 'TNFRSF1A']",0.5311610028490523,0,0,5
85,miRNAs involvement in the immune response in sepsis WP4329,0.09793641050362135,2.5097373414561073,5.831216306615736,"['IRF7', 'TAB2', 'ICAM1', 'NFKB2']",0.5311610028490523,0,0,4
86,TYROBP causal network in microglia WP3945,0.11067808410176584,2.384060721062619,5.247626226673497,"['MAF', 'IGSF6', 'IL18', 'IL13RA1']",0.5864666295507363,0,0,4
87,White fat cell differentiation WP4149,0.11067808410176584,2.384060721062619,5.247626226673497,"['CEBPB', 'CEBPD', 'KLF4', 'KLF2']",0.5864666295507363,0,0,4
88,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.11356667194801308,1.8153725230629214,3.94909820531527,"['LAMA5', 'CD151', 'LAMB2', 'PLCE1', 'MYH9', 'VIM', 'AGRN']",0.594934497364023,0,0,7
89,Pregnane X receptor pathway WP2876,0.12226692596564039,2.7497630331753555,5.778760945563052,"['HSP90AA1', 'CYP3A5', 'CYP3A7']",0.6086815579267467,0,0,3
90,IL-18 signaling pathway WP4754,0.12233600145874315,1.3763875521334616,2.8917681003291444,"['CEBPB', 'HSPB8', 'IL18', 'PLOD3', 'HSPB1', 'TNFRSF11B', 'TACR1', 'KLF2', 'ICAM1', 'VEGFA', 'NFKB2', 'TNFRSF1A', 'ACTA2', 'SOCS3', 'CLDN4', 'NFKBIZ', 'HMOX1', 'KIFC3', 'PTPN7']",0.6086815579267467,0,0,19
91,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.12312059088946802,3.970328282828283,8.316213849212795,"['SMAD1', 'SMAD9']",0.6086815579267467,0,0,2
92,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.12312059088946802,3.970328282828283,8.316213849212795,"['EGF', 'VIM']",0.6086815579267467,0,0,2
93,Signal transduction through IL1R WP4496,0.12411294239721084,2.270353302611367,4.737235884128593,"['IRAK2', 'IL1R1', 'IL1RAP', 'MAP3K14']",0.6086815579267467,0,0,4
94,Vitamin B12 metabolism WP1533,0.12411294239721084,2.270353302611367,4.737235884128593,"['APOE', 'SOD3', 'ICAM1', 'NFKB2']",0.6086815579267467,0,0,4
95,Ferroptosis WP4313,0.13100283756147477,1.9870212092434314,4.038692727200856,"['STEAP3', 'HMOX1', 'SAT1', 'CP', 'SLC39A14']",0.635708506482525,0,0,5
96,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.13708077333916951,1.6454515599343185,3.269816560181756,"['FZD1', 'SFRP4', 'FZD5', 'H2AFY2', 'WIF1', 'WNT7B', 'FZD7', 'FZD9']",0.6469861439332586,0,0,8
97,Oxidation by Cytochrome P450 WP43,0.13819812237875415,2.1669829222011385,4.288604291214279,"['CYP39A1', 'CYP4F3', 'CYP3A5', 'CYP3A7']",0.6469861439332586,0,0,4
98,Angiogenesis WP1539,0.14034406592912332,2.5531482735274205,5.013510690156983,"['SMAD1', 'FGF2', 'VEGFA']",0.6469861439332586,0,0,3
99,Microglia Pathogen Phagocytosis Pathway WP3937,0.14034406592912332,2.5531482735274205,5.013510690156983,"['PIK3R3', 'PIK3CD', 'PIK3C2A']",0.6469861439332586,0,0,3
100,Monoamine Transport WP727,0.14034406592912332,2.5531482735274205,5.013510690156983,"['IL1R1', 'TNFRSF11B', 'FBXO32']",0.6469861439332586,0,0,3
101,Aflatoxin B1 metabolism WP699,0.1490994154650656,11.904446546830652,22.65585194385953,['EPHX1'],0.6669738059390113,0,0,1
102,Cancer immunotherapy by CTLA4 blockade WP4582,0.15046697574329107,3.402867965367965,6.44507156692182,"['PIK3CD', 'PIK3R3']",0.6669738059390113,0,0,2
103,Dopamine metabolism WP2436,0.15046697574329107,3.402867965367965,6.44507156692182,"['NQO1', 'MAOB']",0.6669738059390113,0,0,2
104,Thiamine metabolic pathways WP4297,0.15046697574329107,3.402867965367965,6.44507156692182,"['SLC19A3', 'SLC19A2']",0.6669738059390113,0,0,2
105,IL17 signaling pathway WP2112,0.15288796735750884,2.072601270522234,3.8924485369277653,"['CEBPB', 'CEBPD', 'MAP3K14', 'IL17RB']",0.6694631800158934,0,0,4
106,Interferon type I signaling pathways WP585,0.1539329654700319,1.7448298247241028,3.2649919771017855,"['IFNAR2', 'SOCS3', 'IRS1', 'PDCD4', 'PIK3CD', 'IRS2']",0.6694631800158934,0,0,6
107,TGF-beta Receptor Signaling WP560,0.1555097861960884,1.8625356125356125,3.4662655981554034,"['TGFBR3', 'SMAD1', 'EGF', 'SMAD9', 'ENG']",0.6700001068822127,0,0,5
108,Ebstein-Barr virus LMP1 signaling WP262,0.1592451280730283,2.382748815165877,4.377849602692219,"['HSP90AA1', 'MAP3K14', 'NFKB2']",0.6781010850405669,0,0,3
109,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.16033192683171754,1.6367418518311225,2.996070804931047,"['TUBA1C', 'GPR37', 'HSPA5', 'RNF19A', 'HSPA2', 'HSPA1B', 'HSPA1A']",0.6781010850405669,0,0,7
110,Notch Signaling WP268,0.16842111738815632,1.805951250395695,3.2169189023981257,"['LFNG', 'NOTCH3', 'NUMBL', 'HES1', 'HES5']",0.7058375919630914,0,0,5
111,Cardiac Progenitor Differentiation WP2406,0.17886223109901586,2.233649289099526,3.8444218601181173,"['BMP1', 'CXCR4', 'FGF2']",0.7362097190771992,0,0,3
112,Genes controlling nephrogenesis WP4823,0.17886223109901586,2.233649289099526,3.8444218601181173,"['LAMB2', 'CXCR4', 'VEGFA']",0.7362097190771992,0,0,3
113,MECP2 and Associated Rett Syndrome WP3584,0.18114381943275049,1.5747266754034792,2.6903638044191527,"['CSRP1', 'CEBPD', 'BCL6', 'BDNF', 'FGF2', 'IGF1R', 'GRIA4']",0.7390026615796281,0,0,7
114,DNA damage response WP707,0.18866117546369204,1.6254752851711027,2.7109718990202905,"['CCNB3', 'CCNE2', 'GADD45A', 'SESN1', 'CHEK2', 'PML']",0.745573111145367,0,0,6
115,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.1990893025679491,2.1020908837468637,3.392778466548907,"['FZD1', 'LAMA5', 'GLI2']",0.745573111145367,0,0,3
116,Neural Crest Cell Migration during Development WP4564,0.2001004932337716,1.8330170777988615,2.949206381395613,"['BDNF', 'PIK3R3', 'PIK3CD', 'EPHB1']",0.745573111145367,0,0,4
117,Glutathione metabolism WP100,0.20794099620588297,2.646254208754209,4.155944647201495,"['GPX2', 'GPX3']",0.745573111145367,0,0,2
118,"GPCRs, Class B Secretin-like WP334",0.20794099620588297,2.646254208754209,4.155944647201495,"['CALCRL', 'ADGRG2']",0.745573111145367,0,0,2
119,Kynurenine Pathway and links to Cellular Senescence WP5044,0.20794099620588297,2.646254208754209,4.155944647201495,"['AADAT', 'HAAO']",0.745573111145367,0,0,2
120,miR-509-3p alteration of YAP1/ECM axis WP3967,0.20794099620588297,2.646254208754209,4.155944647201495,"['EDNRA', 'TEAD3']",0.745573111145367,0,0,2
121,Nicotine Activity on Dopaminergic Neurons WP1602,0.20794099620588297,2.646254208754209,4.155944647201495,"['CHRNA4', 'ADCY2']",0.745573111145367,0,0,2
122,Tryptophan catabolism leading to NAD+ production WP4210,0.20794099620588297,2.646254208754209,4.155944647201495,"['AADAT', 'HAAO']",0.745573111145367,0,0,2
123,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.20945096755182466,1.655059618022581,2.587297786849032,"['TGFBR3', 'SMAD1', 'EGF', 'SMAD9', 'ENG']",0.745573111145367,0,0,5
124,IL-1 signaling pathway WP195,0.2133381071050493,1.554554471813523,2.4015954712804217,"['IL1R1', 'IRAK2', 'HSPB2', 'TAB2', 'IL1RAP', 'MAP3K14']",0.745573111145367,0,0,6
125,miRNA regulation of DNA damage response WP1530,0.2133381071050493,1.554554471813523,2.4015954712804217,"['CCNB3', 'CCNE2', 'GADD45A', 'SESN1', 'CHEK2', 'PML']",0.745573111145367,0,0,6
126,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.2133381071050493,1.554554471813523,2.4015954712804217,"['PLCE1', 'PRKCQ', 'ETS1', 'IFI44L', 'TNFRSF1A', 'NFKB2']",0.745573111145367,0,0,6
127,Notch Signaling Pathway Netpath WP61,0.2133381071050493,1.554554471813523,2.4015954712804217,"['PSENEN', 'HES6', 'NOTCH3', 'NUMBL', 'HES1', 'HES5']",0.745573111145367,0,0,6
128,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.2150974239907807,1.3524847625518173,2.0783149408803148,"['FZD1', 'NOTCH3', 'CLDN4', 'CLDN20', 'FZD5', 'FZD7', 'ID2', 'WNT7B', 'FZD9', 'PIK3R3', 'PIK3CD']",0.745573111145367,0,0,11
129,COVID-19 adverse outcome pathway WP4891,0.2151002685083163,5.951750236518448,9.145762919449503,['IL7'],0.745573111145367,0,0,1
130,EV release from cardiac cells and their functional effects WP3297,0.2151002685083163,5.951750236518448,9.145762919449503,['KLF2'],0.745573111145367,0,0,1
131,Hypothetical Craniofacial Development Pathway WP3655,0.2151002685083163,5.951750236518448,9.145762919449503,['ARHGAP29'],0.745573111145367,0,0,1
132,let-7 inhibition of ES cell reprogramming WP3299,0.2151002685083163,5.951750236518448,9.145762919449503,['KLF4'],0.745573111145367,0,0,1
133,Metabolism of alpha-linolenic acid WP4586,0.2151002685083163,5.951750236518448,9.145762919449503,['ALOX12'],0.745573111145367,0,0,1
134,Wnt signaling WP428,0.22160426201062072,1.3935721094920333,2.0999209834175767,"['FZD1', 'SFRP4', 'FZD5', 'DAAM2', 'WIF1', 'FZD7', 'WNT7B', 'FZD9', 'NFATC2']",0.7623848118425086,0,0,9
135,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.2325982126397761,1.324949591425236,1.932363090211531,"['GJA1', 'CEBPB', 'CHRNA4', 'BDNF', 'PAH', 'HES1', 'TACR1', 'HES5', 'GCK', 'NFKB2', 'VEGFA']",0.7714216477360436,0,0,11
136,Cancer immunotherapy by PD-1 blockade WP4585,0.23746339356768498,2.381439393939394,3.4238949601990165,"['NFATC2', 'PDCD1LG2']",0.7714216477360436,0,0,2
137,Cell Differentiation - Index expanded WP2023,0.23746339356768498,2.381439393939394,3.4238949601990165,"['ID2', 'KLF4']",0.7714216477360436,0,0,2
138,Fatty acid transporters WP5061,0.23746339356768498,2.381439393939394,3.4238949601990165,"['DBI', 'ACSBG2']",0.7714216477360436,0,0,2
139,FOXA2 pathway WP5066,0.23746339356768498,2.381439393939394,3.4238949601990165,"['IRS1', 'IRS2']",0.7714216477360436,0,0,2
140,Overview of nanoparticle effects WP3287,0.23746339356768498,2.381439393939394,3.4238949601990165,"['PIK3CD', 'HMOX1']",0.7714216477360436,0,0,2
141,One-carbon metabolism and related pathways WP3940,0.23841951682205484,1.5677013045434098,2.24765017195317,"['GPX2', 'BHMT', 'GPX3', 'CHDH', 'SOD3']",0.7714216477360436,0,0,5
142,Regulatory circuits of the STAT3 signaling pathway WP4538,0.23904967906719887,1.4895437262357414,2.1316620247714035,"['IFNAR2', 'SOCS3', 'IL3RA', 'IFNLR1', 'OSMR', 'IL12RB2']",0.7714216477360436,0,0,6
143,Heart Development WP1591,0.24096467955312426,1.8805188326265903,2.6761755917741183,"['SMAD1', 'NFATC2', 'VEGFA']",0.7714216477360436,0,0,3
144,TLR4 Signaling and Tolerance WP3851,0.24096467955312426,1.8805188326265903,2.6761755917741183,"['INPP5D', 'IRF7', 'TAB2']",0.7714216477360436,0,0,3
145,Aryl Hydrocarbon Receptor Netpath WP2586,0.25097163448560816,1.643002028397566,2.271311234413206,"['NQO1', 'HSP90AA1', 'KLF6', 'VEGFA']",0.7842415557362317,0,0,4
146,Glycolysis and Gluconeogenesis WP534,0.25097163448560816,1.643002028397566,2.271311234413206,"['PGAM2', 'HK2', 'GCK', 'PFKP']",0.7842415557362317,0,0,4
147,Neural Crest Cell Migration in Cancer WP4565,0.25097163448560816,1.643002028397566,2.271311234413206,"['BDNF', 'PIK3R3', 'PIK3CD', 'EPHB1']",0.7842415557362317,0,0,4
148,Pre-implantation embryo WP3527,0.2624189202954633,1.786350710900474,2.389803417476464,"['ZFP36', 'H2AFY2', 'KLF4']",0.7842415557362317,0,0,3
149,Prostaglandin Synthesis and Regulation WP98,0.2624189202954633,1.786350710900474,2.389803417476464,"['HSD11B1', 'EDNRA', 'S100A6']",0.7842415557362317,0,0,3
150,Canonical and non-canonical TGF-B signaling WP3874,0.26717443034763105,2.164772727272727,2.8571829402544253,"['BMP1', 'LOXL2']",0.7842415557362317,0,0,2
151,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.26717443034763105,2.164772727272727,2.8571829402544253,"['EGF', 'HSPB1']",0.7842415557362317,0,0,2
152,Genotoxicity pathway WP4286,0.26839371390960226,1.4890788224121558,1.9585858140454426,"['ACTA2', 'ITPKC', 'CEBPD', 'GADD45A', 'ID2']",0.7842415557362317,0,0,5
153,Phosphoinositides metabolism WP4971,0.26839371390960226,1.4890788224121558,1.9585858140454426,"['MTMR11', 'INPP5D', 'PIK3CD', 'PLCE1', 'PIK3C2A']",0.7842415557362317,0,0,5
154,Benzo(a)pyrene metabolism WP696,0.27598616998424685,3.967518133081047,5.107800790696988,['EPHX1'],0.7842415557362317,0,0,1
155,Cells and molecules involved in local acute inflammatory response  WP4493,0.27598616998424685,3.967518133081047,5.107800790696988,['ICAM1'],0.7842415557362317,0,0,1
156,Composition of Lipid Particles WP3601,0.27598616998424685,3.967518133081047,5.107800790696988,['APOE'],0.7842415557362317,0,0,1
157,FTO Obesity Variant Mechanism WP3407,0.27598616998424685,3.967518133081047,5.107800790696988,['ARID5B'],0.7842415557362317,0,0,1
158,GABA metabolism (aka GHB) WP4157,0.27598616998424685,3.967518133081047,5.107800790696988,['ADHFE1'],0.7842415557362317,0,0,1
159,Irinotecan pathway WP229,0.27598616998424685,3.967518133081047,5.107800790696988,['CYP3A5'],0.7842415557362317,0,0,1
160,Small Ligand GPCRs WP247,0.27598616998424685,3.967518133081047,5.107800790696988,['S1PR3'],0.7842415557362317,0,0,1
161,Tamoxifen metabolism WP691,0.27598616998424685,3.967518133081047,5.107800790696988,['CYP3A5'],0.7842415557362317,0,0,1
162,The alternative pathway of fetal androgen synthesis WP4524,0.27598616998424685,3.967518133081047,5.107800790696988,['HSD17B6'],0.7842415557362317,0,0,1
163,16p11.2 distal deletion syndrome WP4950,0.2840961817959885,1.7011509817197021,2.1408005749946777,"['PLN', 'NFATC2', 'ATP2A1']",0.7842415557362317,0,0,3
164,Aryl Hydrocarbon Receptor Pathway WP2873,0.2840961817959885,1.7011509817197021,2.1408005749946777,"['NQO1', 'HSP90AA1', 'HES1']",0.7842415557362317,0,0,3
165,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.2840961817959885,1.7011509817197021,2.1408005749946777,"['HSPB8', 'HSPB1', 'NDRG1']",0.7842415557362317,0,0,3
166,MTHFR deficiency WP4288,0.2840961817959885,1.7011509817197021,2.1408005749946777,"['BHMT', 'CHDH', 'GRIN2D']",0.7842415557362317,0,0,3
167,Tryptophan metabolism WP465,0.2840961817959885,1.7011509817197021,2.1408005749946777,"['MAOB', 'AADAT', 'HAAO']",0.7842415557362317,0,0,3
168,Nephrotic syndrome WP4758,0.28624917005674144,1.536757054538777,1.9223180636079973,"['CD151', 'LAMB2', 'PLCE1', 'MYH9']",0.7854813535485584,0,0,4
169,Cysteine and methionine catabolism WP4504,0.29686748341443264,1.9842171717171717,2.4097710847112057,"['BHMT', 'SQOR']",0.7933814052436289,0,0,2
170,Imatinib and Chronic Myeloid Leukemia WP3640,0.29686748341443264,1.9842171717171717,2.4097710847112057,"['GADD45A', 'PIM1']",0.7933814052436289,0,0,2
171,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.29686748341443264,1.9842171717171717,2.4097710847112057,"['TNC', 'VIM']",0.7933814052436289,0,0,2
172,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.29878521388059126,1.323712866053494,1.5990852665142896,"['FZD1', 'EGF', 'PIK3CD', 'PIK3R3', 'FGF2', 'MAP3K14', 'IGF1R']",0.7933814052436289,0,0,7
173,Endometrial cancer WP4155,0.30675075089489523,1.3484826745103666,1.5935286056156728,"['EGF', 'GADD45A', 'PIK3CD', 'PIK3R3', 'FGF2', 'FGFR3']",0.7933814052436289,0,0,6
174,Regulation of toll-like receptor signaling pathway WP1449,0.3143030515582643,1.2707555555555556,1.4707694634340802,"['IFNAR2', 'IRAK2', 'SFTPD', 'IRF7', 'PIK3R3', 'PIK3CD', 'TAB2', 'NFKB2']",0.7933814052436289,0,0,8
175,Cardiac Hypertrophic Response WP2795,0.31470218284741,1.384858322842819,1.601074229033221,"['EGF', 'NFATC2', 'FGF2', 'MAP3K14', 'TNFRSF1A']",0.7933814052436289,0,0,5
176,RANKL/RANK signaling pathway WP2018,0.31470218284741,1.384858322842819,1.601074229033221,"['SPI1', 'TNFRSF11B', 'TAB2', 'ICAM1', 'NFKB2']",0.7933814052436289,0,0,5
177,Constitutive Androstane Receptor Pathway WP2875,0.32636678921411016,1.831439393939394,2.0507238774182035,"['HSP90AA1', 'CYP3A5']",0.7933814052436289,0,0,2
178,ERK Pathway in Huntington's Disease WP3853,0.32636678921411016,1.831439393939394,2.0507238774182035,"['EGF', 'BDNF']",0.7933814052436289,0,0,2
179,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.32636678921411016,1.831439393939394,2.0507238774182035,"['ACTN1', 'PRKCQ']",0.7933814052436289,0,0,2
180,Monoamine GPCRs WP58,0.32636678921411016,1.831439393939394,2.0507238774182035,"['CHRM5', 'HTR2B']",0.7933814052436289,0,0,2
181,NAD+ metabolism WP3644,0.32636678921411016,1.831439393939394,2.0507238774182035,"['NT5E', 'CD38']",0.7933814052436289,0,0,2
182,Overview of interferons-mediated signaling pathway WP4558,0.32636678921411016,1.831439393939394,2.0507238774182035,"['IFNAR2', 'IFNLR1']",0.7933814052436289,0,0,2
183,Oxysterols derived from cholesterol WP4545,0.3277878062181393,1.5529775396661858,1.7321737733582165,"['CYP39A1', 'HSD3B7', 'ACOT6']",0.7933814052436289,0,0,3
184,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.3277878062181393,1.5529775396661858,1.7321737733582165,"['ACTA2', 'PRKCQ', 'TNFRSF1A']",0.7933814052436289,0,0,3
185,Bile acids synthesis and enterohepatic circulation  WP4389,0.332153169657311,2.975402081362346,3.2793663672676314,['SLC10A1'],0.7933814052436289,0,0,1
186,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.332153169657311,2.975402081362346,3.2793663672676314,['HSD11B1'],0.7933814052436289,0,0,1
187,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.332153169657311,2.975402081362346,3.2793663672676314,['STRADB'],0.7933814052436289,0,0,1
188,miR-517 relationship with ARCN1 and USP1 WP3596,0.332153169657311,2.975402081362346,3.2793663672676314,['ID2'],0.7933814052436289,0,0,1
189,NAD Biosynthesis II (from tryptophan) WP2485,0.332153169657311,2.975402081362346,3.2793663672676314,['HAAO'],0.7933814052436289,0,0,1
190,Osteoblast Signaling WP322,0.332153169657311,2.975402081362346,3.2793663672676314,['TNFRSF11B'],0.7933814052436289,0,0,1
191,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.332153169657311,2.975402081362346,3.2793663672676314,['VEGFA'],0.7933814052436289,0,0,1
192,SARS-CoV-2 and COVID-19 Pathway WP4846,0.332153169657311,2.975402081362346,3.2793663672676314,['NRP1'],0.7933814052436289,0,0,1
193,Serotonin Transporter Activity WP1455,0.332153169657311,2.975402081362346,3.2793663672676314,['IL1R1'],0.7933814052436289,0,0,1
194,Focal Adhesion WP306,0.33438644104508225,1.1735247208931419,1.2855469799867274,"['LAMA5', 'EGF', 'LAMB2', 'ACTN1', 'HGF', 'TNC', 'PIK3R3', 'PIK3CD', 'LAMB1', 'VEGFA', 'IGF1R', 'FLNA', 'FLNB']",0.7945987078442418,0,0,13
195,IL-3 signaling pathway WP286,0.3402569783261957,1.4008259850429736,1.5101662361389705,"['INPP5D', 'IL3RA', 'PIK3CD', 'ENPP3']",0.800298301063144,0,0,4
196,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.3402569783261957,1.4008259850429736,1.5101662361389705,"['IFNAR2', 'CD160', 'CXCL17', 'IRF7']",0.800298301063144,0,0,4
197,Head and Neck Squamous Cell Carcinoma WP4674,0.34886764759614647,1.2759369907658882,1.343641603983656,"['SESN1', 'GAB1', 'FGFR3', 'IGF1R', 'NFKB2', 'VEGFA']",0.8163857134102717,0,0,6
198,VEGFA-VEGFR2 Signaling Pathway WP3888,0.3583138145302956,1.087015292972106,1.1156539062021833,"['PLOD3', 'HSPB1', 'NRARP', 'PBXIP1', 'PLA2G5', 'ETS1', 'NDRG1', 'APOLD1', 'ICAM1', 'TUBA1C', 'STIP1', 'GJA1', 'CSRP1', 'DNAJB4', 'FLNB', 'MYH11', 'ADAMTS9', 'HSP90AA1', 'EGR3', 'GAB1', 'NFATC2', 'RHOC', 'VEGFA', 'DNAJA1', 'TXNIP', 'MYH9', 'ACKR3', 'DSC1', 'ENG', 'HSPA1A', 'EPHA2']",0.8342559015074054,0,0,31
199,p53 transcriptional gene network WP4963,0.361913038175741,1.2942318014781782,1.3153942024703686,"['GADD45A', 'SESN1', 'SAT1', 'PML', 'ICAM1']",0.8384015607990785,0,0,5
200,Aspirin and miRNAs WP4707,0.383966680495486,2.380132450331126,2.2782615906817107,['VEGFA'],0.8434424075287618,0,0,1
201,EDA signaling in hair follicle development WP3930,0.383966680495486,2.380132450331126,2.2782615906817107,['BMP1'],0.8434424075287618,0,0,1
202,Genes targeted by miRNAs in adipocytes WP1992,0.383966680495486,2.380132450331126,2.2782615906817107,['GJA1'],0.8434424075287618,0,0,1
203,LDLRAD4 and what we know about it WP4904,0.383966680495486,2.380132450331126,2.2782615906817107,['NEDD4'],0.8434424075287618,0,0,1
204,"Phase I biotransformations, non P450 WP136",0.383966680495486,2.380132450331126,2.2782615906817107,['PON1'],0.8434424075287618,0,0,1
205,PTF1A related regulatory pathway WP4147,0.383966680495486,2.380132450331126,2.2782615906817107,['HES1'],0.8434424075287618,0,0,1
206,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.383966680495486,2.380132450331126,2.2782615906817107,['IGF1R'],0.8434424075287618,0,0,1
207,Apoptosis Modulation by HSP70 WP384,0.384214545728937,1.5869949494949496,1.518046636042655,"['TNFRSF1A', 'HSPA1A']",0.8434424075287618,0,0,2
208,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.384214545728937,1.5869949494949496,1.518046636042655,"['FGF2', 'GLI2']",0.8434424075287618,0,0,2
209,Statin inhibition of cholesterol production WP430,0.384214545728937,1.5869949494949496,1.518046636042655,"['APOC1', 'APOE']",0.8434424075287618,0,0,2
210,Urea cycle and metabolism of amino groups WP497,0.384214545728937,1.5869949494949496,1.518046636042655,"['ARG2', 'PYCR1']",0.8434424075287618,0,0,2
211,Small cell lung cancer WP4658,0.38882581494587065,1.190675547098002,1.124740474314789,"['LAMA5', 'CCNE2', 'LAMB2', 'GADD45A', 'PIK3CD', 'PIK3R3', 'LAMB1']",0.8454063819230022,0,0,7
212,Wnt signaling pathway and pluripotency WP399,0.38882581494587065,1.190675547098002,1.124740474314789,"['FZD1', 'FZD5', 'FZD7', 'WNT7B', 'ESRRB', 'FZD9', 'PRKCQ']",0.8454063819230022,0,0,7
213,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.39061075780824184,1.1450381679389312,1.0763859379775431,"['SLCO1C1', 'IRS1', 'DIO2', 'TRIP10', 'PIK3R3', 'PIK3CD', 'IRS2', 'MAP3K6', 'PIK3C2A', 'MAP3K14']",0.8454063819230022,0,0,10
214,Development of ureteric collection system WP5053,0.39307174210932616,1.3734597156398105,1.282486048329061,"['SMAD1', 'FREM1', 'GLI2']",0.8467573509925204,0,0,3
215,Integrated breast cancer pathway WP1984,0.40728722962523345,1.1194948530192084,1.0055712712608065,"['BARD1', 'SMAD1', 'ITPKC', 'RASGEF1A', 'IRS1', 'GADD45A', 'CHEK2', 'FILIP1', 'PML', 'RASGRP3', 'VEGFA']",0.868025865825764,0,0,11
216,Bladder cancer WP2828,0.41451298526793295,1.3224855186940494,1.1646481645707298,"['EGF', 'FGFR3', 'VEGFA']",0.868025865825764,0,0,3
217,Mesodermal commitment pathway WP2857,0.41691347769824927,1.1279012593447393,0.9867743808400944,"['SMAD1', 'FZD5', 'ZIC2', 'TRIM5', 'SESN1', 'ARID5B', 'HMGA2', 'TBX6', 'KLF4']",0.868025865825764,0,0,9
218,Apoptosis Modulation and Signaling WP1772,0.41978788897603214,1.1708844979118618,1.016334443427708,"['IL1R1', 'BAG3', 'TNFRSF11B', 'MAP3K14', 'TNFRSF1A', 'HSPA1A']",0.868025865825764,0,0,6
219,MET in type 1 papillary renal cell carcinoma WP4205,0.4249804429267086,1.1903133903133902,1.0185656039257631,"['HGF', 'GAB1', 'PIK3CD', 'PIK3R3', 'ETS1']",0.868025865825764,0,0,5
220,"Cerebral organic acidurias, including diseases WP4519",0.4317638448804883,1.9832860296436456,1.6657153203054904,['ADHFE1'],0.868025865825764,0,0,1
221,Estrogen metabolism WP697,0.4317638448804883,1.9832860296436456,1.6657153203054904,['NQO1'],0.868025865825764,0,0,1
222,Methylation Pathways WP704,0.4317638448804883,1.9832860296436456,1.6657153203054904,['PNMT'],0.868025865825764,0,0,1
223,Nephrogenesis WP5052,0.4317638448804883,1.9832860296436456,1.6657153203054904,['RSPO3'],0.868025865825764,0,0,1
224,Platelet-mediated interactions with vascular and circulating cells WP4462,0.4317638448804883,1.9832860296436456,1.6657153203054904,['ICAM1'],0.868025865825764,0,0,1
225,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.4317638448804883,1.9832860296436456,1.6657153203054904,['MUC1'],0.868025865825764,0,0,1
226,Type III interferon signaling WP2113,0.4317638448804883,1.9832860296436456,1.6657153203054904,['IFNLR1'],0.868025865825764,0,0,1
227,Regulation of Actin Cytoskeleton WP51,0.43332924410347234,1.1022759400621995,0.9217864788800254,"['MRAS', 'EGF', 'ACTN1', 'CHRM5', 'WAS', 'PIK3R3', 'PIK3CD', 'PIK3C2A', 'FGF2', 'FGFR3']",0.868025865825764,0,0,10
228,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.43980317301663496,1.4000668449197862,1.15005408897717,"['H2AFY2', 'BCL6']",0.868025865825764,0,0,2
229,Hippo-Yap signaling pathway WP4537,0.43980317301663496,1.4000668449197862,1.15005408897717,"['NDRG1', 'TEAD3']",0.868025865825764,0,0,2
230,Methionine De Novo and Salvage Pathway WP3580,0.43980317301663496,1.4000668449197862,1.15005408897717,"['BHMT', 'CHDH']",0.868025865825764,0,0,2
231,PKC-gamma calcium signaling pathway in ataxia WP4760,0.43980317301663496,1.4000668449197862,1.15005408897717,"['GNA14', 'GRIA4']",0.868025865825764,0,0,2
232,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.43980317301663496,1.4000668449197862,1.15005408897717,"['IFNAR2', 'IRF7']",0.868025865825764,0,0,2
233,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.43980317301663496,1.4000668449197862,1.15005408897717,"['WIF1', 'PML']",0.868025865825764,0,0,2
234,Oncostatin M Signaling Pathway WP2374,0.4406031509831427,1.1668808074036832,0.956387987281882,"['SOCS3', 'CEBPB', 'IRS1', 'OSMR', 'VEGFA']",0.868025865825764,0,0,5
235,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.45660311232965894,1.2310835103775126,0.9650965040856149,"['GABRA2', 'BDNF', 'PIK3R3']",0.8739820182610308,0,0,3
236,Glioblastoma signaling pathways WP2261,0.46196077131592966,1.115731939163498,0.8616522203545431,"['IRS1', 'GAB1', 'PIK3CD', 'PRKCQ', 'PIK3C2A', 'IGF1R']",0.8739820182610308,0,0,6
237,7-oxo-C and 7beta-HC pathways WP5064,0.466549147402976,1.3221801346801347,1.0080194392401145,"['HSD11B1', 'ACOT6']",0.8739820182610308,0,0,2
238,Canonical and non-canonical Notch signaling WP3845,0.466549147402976,1.3221801346801347,1.0080194392401145,"['NOTCH3', 'HES1']",0.8739820182610308,0,0,2
239,Immune response to tuberculosis WP4197,0.466549147402976,1.3221801346801347,1.0080194392401145,"['IFNAR2', 'IFI35']",0.8739820182610308,0,0,2
240,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.466549147402976,1.3221801346801347,1.0080194392401145,"['CEBPB', 'ATP2C2']",0.8739820182610308,0,0,2
241,Sleep regulation WP3591,0.466549147402976,1.3221801346801347,1.0080194392401145,"['IL18', 'GHRL']",0.8739820182610308,0,0,2
242,B Cell Receptor Signaling Pathway WP23,0.4758556040943218,1.0984790874524715,0.8157754141191478,"['BCL6', 'INPP5D', 'GAB1', 'NFATC2', 'ETS1', 'RASGRP3']",0.8739820182610308,0,0,6
243,Biomarkers for urea cycle disorders WP4583,0.4758557192701057,1.6998243005811595,1.2623585069892036,['F10'],0.8739820182610308,0,0,1
244,Complement Activation WP545,0.4758557192701057,1.6998243005811595,1.2623585069892036,['C1R'],0.8739820182610308,0,0,1
245,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.4758557192701057,1.6998243005811595,1.2623585069892036,['HMOX1'],0.8739820182610308,0,0,1
246,Insulin signaling in adipocytes (diabetic condition) WP3635,0.4758557192701057,1.6998243005811595,1.2623585069892036,['IRS1'],0.8739820182610308,0,0,1
247,Insulin signaling in adipocytes (normal condition) WP3634,0.4758557192701057,1.6998243005811595,1.2623585069892036,['IRS1'],0.8739820182610308,0,0,1
248,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.4758557192701057,1.6998243005811595,1.2623585069892036,['CLDN4'],0.8739820182610308,0,0,1
249,Nanoparticle triggered regulated necrosis WP2513,0.4758557192701057,1.6998243005811595,1.2623585069892036,['TNFRSF1A'],0.8739820182610308,0,0,1
250,Osteoclast Signaling WP12,0.4758557192701057,1.6998243005811595,1.2623585069892036,['TNFRSF11B'],0.8739820182610308,0,0,1
251,RAS and bradykinin pathways in COVID-19 WP4969,0.4758557192701057,1.6998243005811595,1.2623585069892036,['SERPING1'],0.8739820182610308,0,0,1
252,Male infertility WP4673,0.47924329185768466,1.081826831588963,0.795734366168831,"['NANOS1', 'NQO1', 'BHMT', 'MSH5', 'PON1', 'CLU', 'SOD3']",0.8767109426444152,0,0,7
253,Toll-like Receptor Signaling Pathway WP75,0.486778152977383,1.1017902993211635,0.7932303977581403,"['IFNAR2', 'IRF7', 'PIK3R3', 'PIK3CD', 'TAB2']",0.883883552293539,0,0,5
254,EPO Receptor Signaling WP581,0.4925202858714101,1.2524920255183414,0.8870394384291844,"['IRS1', 'IRS2']",0.883883552293539,0,0,2
255,SARS-CoV-2 mitochondrial interactions WP5038,0.4925202858714101,1.2524920255183414,0.8870394384291844,"['IRF7', 'NFKB2']",0.883883552293539,0,0,2
256,Unfolded protein response WP4925,0.4925202858714101,1.2524920255183414,0.8870394384291844,"['HSPA5', 'TXNIP']",0.883883552293539,0,0,2
257,DNA Replication WP466,0.497359098282326,1.1514753095856902,0.8042398489617861,"['RPA3', 'UBC', 'CDC7']",0.883883552293539,0,0,3
258,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.5000251586770041,1.106835532412515,0.7671442370011035,"['BDNF', 'PIK3CD', 'PIK3R3', 'GRIN2D']",0.883883552293539,0,0,4
259,DNA damage response (only ATM dependent) WP710,0.5045053314560682,1.0542701947512314,0.72130728349986,"['BCL6', 'IRS1', 'WNT7B', 'PIK3R3', 'PIK3CD', 'PIK3C2A', 'NFKB2']",0.883883552293539,0,0,7
260,"Degradation pathway of sphingolipids, including diseases WP4153",0.5165292908562537,1.487228003784295,0.9824974445807862,['NEU4'],0.883883552293539,0,0,1
261,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.5165292908562537,1.487228003784295,0.9824974445807862,['CEBPB'],0.883883552293539,0,0,1
262,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.5165292908562537,1.487228003784295,0.9824974445807862,['APOE'],0.883883552293539,0,0,1
263,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.5165292908562537,1.487228003784295,0.9824974445807862,['BHMT'],0.883883552293539,0,0,1
264,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.5165292908562537,1.487228003784295,0.9824974445807862,['PRKCQ'],0.883883552293539,0,0,1
265,NLR Proteins WP288,0.5165292908562537,1.487228003784295,0.9824974445807862,['ERBIN'],0.883883552293539,0,0,1
266,Serotonin and anxiety-related events WP3944,0.5165292908562537,1.487228003784295,0.9824974445807862,['GRIN2D'],0.883883552293539,0,0,1
267,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.5165292908562537,1.487228003784295,0.9824974445807862,['KLF4'],0.883883552293539,0,0,1
268,T-cell receptor (TCR) signaling pathway WP69,0.5167971728521595,1.0622710622710623,0.7012102239364267,"['WAS', 'NFATC2', 'PRKCQ', 'VIM', 'MAP3K14']",0.883883552293539,0,0,5
269,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.5176758332304892,1.1897727272727272,0.7833535465256279,"['TGFBR3', 'HGF']",0.883883552293539,0,0,2
270,Toll-like Receptor Signaling related to MyD88 WP3858,0.5176758332304892,1.1897727272727272,0.7833535465256279,"['IRF7', 'NFKB2']",0.883883552293539,0,0,2
271,Hedgehog Signaling Pathway WP4249,0.5365141657543068,1.081516587677725,0.6734196202956894,"['HHIP', 'BOC', 'GLI2']",0.9101406081041741,0,0,3
272,Cell migration and invasion through p75NTR WP4561,0.541986001261459,1.1330266955266954,0.6939959662926045,"['EFNA1', 'BDNF']",0.9101406081041741,0,0,2
273,Endothelin Pathways WP2197,0.541986001261459,1.1330266955266954,0.6939959662926045,"['EDNRA', 'CALCRL']",0.9101406081041741,0,0,2
274,Senescence and Autophagy in Cancer WP615,0.5434773191890647,1.019608908202064,0.6217241754094397,"['CEBPB', 'IGFBP5', 'IRF7', 'COL10A1', 'SLC39A1', 'IGF1R']",0.9101406081041741,0,0,6
275,Ras signaling WP4223,0.5471418190673235,0.9987313808263523,0.602282205835296,"['MRAS', 'GAB1', 'PLCE1', 'PIK3R3', 'PIK3CD', 'PLA2G5', 'ETS1', 'FGFR3', 'IGF1R', 'EPHA2', 'RASGRP3']",0.9101406081041741,0,0,11
276,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.5540493380349525,1.321875328497845,0.7805694150185202,['SMAD1'],0.9101406081041741,0,0,1
277,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.5540493380349525,1.321875328497845,0.7805694150185202,['PRKCQ'],0.9101406081041741,0,0,1
278,Iron metabolism in placenta WP2007,0.5540493380349525,1.321875328497845,0.7805694150185202,['STEAP3'],0.9101406081041741,0,0,1
279,Major receptors targeted by epinephrine and norepinephrine WP4589,0.5540493380349525,1.321875328497845,0.7805694150185202,['ADCY2'],0.9101406081041741,0,0,1
280,Osteopontin Signaling WP1434,0.5540493380349525,1.321875328497845,0.7805694150185202,['MAP3K14'],0.9101406081041741,0,0,1
281,TNF-alpha signaling pathway WP231,0.5565464533454345,1.005167889466074,0.5890330448284243,"['HSP90AA1', 'OTUD7B', 'TAB2', 'MAP3K14', 'TNFRSF1A', 'NFKB2']",0.9101406081041741,0,0,6
282,Insulin Signaling WP481,0.5567454479075424,0.991085641515441,0.5804264804334738,"['SOCS3', 'IRS1', 'GAB1', 'PIK3R3', 'PIK3CD', 'IRS2', 'PRKCQ', 'MAP3K6', 'PIK3C2A', 'MAP3K14', 'IGF1R']",0.9101406081041741,0,0,11
283,Gastric Cancer Network 2 WP2363,0.5654305154126102,1.081439393939394,0.6166019890813536,"['DSCC1', 'S100A6']",0.9210723236933334,0,0,2
284,Resistin as a regulator of inflammation WP4481,0.5879973205706958,1.0343379446640317,0.549267465867537,"['PIK3CD', 'PLCE1']",0.9311698140989962,0,0,2
285,DNA IR-damage and cellular response via ATR WP4016,0.5882763910170158,0.9748104556847726,0.5171938647278401,"['BARD1', 'BCL6', 'CHEK2', 'FANCA', 'PML']",0.9311698140989962,0,0,5
286,Biomarkers for pyrimidine metabolism disorders WP4584,0.5886601478626482,1.189593188268685,0.6303728777852394,['DHODH'],0.9311698140989962,0,0,1
287,Dopaminergic Neurogenesis WP2855,0.5886601478626482,1.189593188268685,0.6303728777852394,['GLI2'],0.9311698140989962,0,0,1
288,Ganglio Sphingolipid Metabolism WP1423,0.5886601478626482,1.189593188268685,0.6303728777852394,['ST8SIA1'],0.9311698140989962,0,0,1
289,GDNF/RET signaling axis WP4830,0.5886601478626482,1.189593188268685,0.6303728777852394,['IFT27'],0.9311698140989962,0,0,1
290,GPR40 Pathway WP3958,0.5886601478626482,1.189593188268685,0.6303728777852394,['PLCE1'],0.9311698140989962,0,0,1
291,ID signaling pathway WP53,0.5886601478626482,1.189593188268685,0.6303728777852394,['ID2'],0.9311698140989962,0,0,1
292,Netrin-UNC5B signaling pathway WP4747,0.5918281031041343,0.9911532385466034,0.5198985807690586,"['INPP5D', 'NTN1', 'ICAM1']",0.9311698140989962,0,0,3
293,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.5918281031041343,0.9911532385466034,0.5198985807690586,"['NFATC2', 'PRKCQ', 'MAP3K14']",0.9311698140989962,0,0,3
294,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.6096814304904198,0.9911616161616161,0.49044530569948,"['PIK3CD', 'PRKCQ']",0.9380021414764997,0,0,2
295,One-carbon metabolism WP241,0.6096814304904198,0.9911616161616161,0.49044530569948,"['BHMT', 'CHDH']",0.9380021414764997,0,0,2
296,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.6096814304904198,0.9911616161616161,0.49044530569948,"['NDRG1', 'TEAD3']",0.9380021414764997,0,0,2
297,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.6096814304904198,0.9911616161616161,0.49044530569948,"['ANGPT2', 'VEGFA']",0.9380021414764997,0,0,2
298,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.6117246013423374,0.95134724857685,0.46756157720660235,"['FZD1', 'FZD5', 'FZD7', 'FZD9']",0.9380021414764997,0,0,4
299,Alzheimer's disease WP2059,0.6151937424970385,0.9437133511207585,0.45847296333088206,"['PSENEN', 'ATP2A1', 'APOE', 'TNFRSF1A', 'GRIN2D']",0.9380021414764997,0,0,5
300,BMP Signaling Pathway in Eyelid Development WP3927,0.620587100109181,1.0813623462630084,0.515906419254425,['SMAD1'],0.9380021414764997,0,0,1
301,Computational Model of Aerobic Glycolysis WP4629,0.620587100109181,1.0813623462630084,0.515906419254425,['PGAM2'],0.9380021414764997,0,0,1
302,Galanin receptor pathway WP4970,0.620587100109181,1.0813623462630084,0.515906419254425,['VEGFA'],0.9380021414764997,0,0,1
303,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.620587100109181,1.0813623462630084,0.515906419254425,['NFKB2'],0.9380021414764997,0,0,1
304,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.620587100109181,1.0813623462630084,0.515906419254425,['MAP3K14'],0.9380021414764997,0,0,1
305,Pyrimidine metabolism and related diseases WP4225,0.620587100109181,1.0813623462630084,0.515906419254425,['DHODH'],0.9380021414764997,0,0,1
306,Modulators of TCR signaling and T cell activation WP5072,0.6262428575372209,0.9388376153654278,0.4393919940651333,"['PRKCQ', 'MAP3K14', 'ZFP36L1']",0.9434573768779699,0,0,3
307,Cytosolic DNA-sensing pathway WP4655,0.6426838504757095,0.9146919431279621,0.4043874617403399,"['RNF125', 'IL18', 'IRF7']",0.9488590072146602,0,0,3
308,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.6426838504757095,0.9146919431279621,0.4043874617403399,"['PIM1', 'PDCD4', 'PIK3R3']",0.9488590072146602,0,0,3
309,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.6500381297640606,0.9911699779249448,0.4269209519431052,['CD38'],0.9488590072146602,0,0,1
310,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.6500381297640606,0.9911699779249448,0.4269209519431052,['SYTL4'],0.9488590072146602,0,0,1
311,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.6500381297640606,0.9911699779249448,0.4269209519431052,['ALOX12'],0.9488590072146602,0,0,1
312,Hedgehog Signaling Pathway Netpath WP47,0.6500381297640606,0.9911699779249448,0.4269209519431052,['GLI2'],0.9488590072146602,0,0,1
313,Omega-3/Omega-6 FA synthesis WP4723,0.6500381297640606,0.9911699779249448,0.4269209519431052,['PLA2G5'],0.9488590072146602,0,0,1
314,PPAR-alpha pathway WP2878,0.6500381297640606,0.9911699779249448,0.4269209519431052,['DBI'],0.9488590072146602,0,0,1
315,TP53 network WP1742,0.6500381297640606,0.9911699779249448,0.4269209519431052,['GADD45A'],0.9488590072146602,0,0,1
316,BDNF-TrkB Signaling WP3676,0.6504109463770773,0.9147727272727273,0.3934903033943397,"['BDNF', 'GAB1']",0.9488590072146602,0,0,2
317,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.6586077369688839,0.8917535545023697,0.3724205057329198,"['PPP1R3G', 'HSPA5', 'PPP1R3C']",0.9577860149610583,0,0,3
318,Prion disease pathway WP3995,0.6694730918078395,0.8808221099887766,0.35344247279132457,"['SPI1', 'HSPA5']",0.9604056111218777,0,0,2
319,Synaptic Vesicle Pathway WP2267,0.6740127729866557,0.8699341116633915,0.34319441563220543,"['SLC22A3', 'SLC38A1', 'SYN3']",0.9604056111218777,0,0,3
320,Calcium Regulation in the Cardiac Cell WP536,0.6767411474802596,0.888437917222964,0.34690518315073593,"['RGS17', 'GJA1', 'PLN', 'GRK5', 'CHRM5', 'GJA9', 'PRKCQ', 'ADCY2']",0.9604056111218777,0,0,8
321,Airway smooth muscle cell contraction WP4962,0.677205075717935,0.9148533585619678,0.35659257917600895,['CD38'],0.9604056111218777,0,0,1
322,Cori Cycle WP1946,0.677205075717935,0.9148533585619678,0.35659257917600895,['PFKP'],0.9604056111218777,0,0,1
323,SARS coronavirus and innate immunity WP4912,0.677205075717935,0.9148533585619678,0.35659257917600895,['IFNAR2'],0.9604056111218777,0,0,1
324,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.677205075717935,0.9148533585619678,0.35659257917600895,['NQO1'],0.9604056111218777,0,0,1
325,Type II diabetes mellitus WP1584,0.677205075717935,0.9148533585619678,0.35659257917600895,['IRS1'],0.9604056111218777,0,0,1
326,ATM Signaling Pathway WP2516,0.6876845097177635,0.8492965367965368,0.3179979472397382,"['GADD45A', 'CHEK2']",0.9604056111218777,0,0,2
327,"GPCRs, Other WP117",0.6876845097177635,0.8492965367965368,0.3179979472397382,"['EDNRA', 'GNRHR']",0.9604056111218777,0,0,2
328,Pathways Regulating Hippo Signaling WP4540,0.6894037309817393,0.8612384216248951,0.3203188671116234,"['PRKCQ', 'FGFR3', 'IGF1R', 'EPHA2', 'TEAD3']",0.9604056111218777,0,0,5
329,Melanoma WP4685,0.6941582856780787,0.8490105719707238,0.309935781151281,"['GADD45A', 'PIK3CD', 'PIK3R3', 'ETS1']",0.9604056111218777,0,0,4
330,Ectoderm Differentiation WP2858,0.6953844294726752,0.8719965050240279,0.3167880030650164,"['FZD5', 'BOC', 'PIM1', 'HESX1', 'RHPN1', 'TNFRSF11B', 'KIFC3', 'ARHGAP15']",0.9604056111218777,0,0,8
331,Myometrial relaxation and contraction pathways WP289,0.6953844294726752,0.8719965050240279,0.3167880030650164,"['ACTA2', 'RGS17', 'GJA1', 'IGFBP5', 'GRK5', 'ACKR3', 'PRKCQ', 'ADCY2']",0.9604056111218777,0,0,8
332,G1 to S cell cycle control WP45,0.7032693811822555,0.8293397994048275,0.2919402755184848,"['CCNE2', 'GADD45A', 'RPA3']",0.9604056111218777,0,0,3
333,Oxidative Damage WP3941,0.7050623718599868,0.8199451410658307,0.2865454161776463,"['C1R', 'GADD45A']",0.9604056111218777,0,0,2
334,Type 2 papillary renal cell carcinoma WP4241,0.7050623718599868,0.8199451410658307,0.2865454161776463,"['EGLN3', 'VEGFA']",0.9604056111218777,0,0,2
335,Vitamin D-sensitive calcium signaling in depression WP4698,0.7050623718599868,0.8199451410658307,0.2865454161776463,"['ATP2B4', 'GRIN2D']",0.9604056111218777,0,0,2
336,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.717126926894134,0.8104265402843602,0.26946879324568934,"['DDX3Y', 'RNF125', 'IRF7']",0.9604056111218777,0,0,3
337,NO/cGMP/PKG mediated Neuroprotection WP4008,0.7216263034568198,0.7925505050505051,0.25856790567781257,"['TSPO', 'GRIN2D']",0.9604056111218777,0,0,2
338,Signaling of Hepatocyte Growth Factor Receptor WP313,0.7216263034568198,0.7925505050505051,0.25856790567781257,"['HGF', 'GAB1']",0.9604056111218777,0,0,2
339,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.725380966127222,0.7927467675812047,0.2545179228856658,['MKNK2'],0.9604056111218777,0,0,1
340,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.725380966127222,0.7927467675812047,0.2545179228856658,['PLA2G5'],0.9604056111218777,0,0,1
341,miRNA targets in ECM and membrane receptors WP2911,0.725380966127222,0.7927467675812047,0.2545179228856658,['LAMB2'],0.9604056111218777,0,0,1
342,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.725380966127222,0.7927467675812047,0.2545179228856658,['BCL2L14'],0.9604056111218777,0,0,1
343,"Relationship between inflammation, COX-2 and EGFR WP4483",0.725380966127222,0.7927467675812047,0.2545179228856658,['PIK3CD'],0.9604056111218777,0,0,1
344,Transcription co-factors SKI and SKIL protein partners WP4533,0.725380966127222,0.7927467675812047,0.2545179228856658,['TEAD3'],0.9604056111218777,0,0,1
345,Cell cycle WP179,0.7276655479370683,0.8288531258289857,0.26350380420639774,"['CCNB3', 'CCNE2', 'GADD45A', 'CHEK2', 'CDC7', 'SMC1B']",0.9604056111218777,0,0,6
346,Prolactin Signaling Pathway WP2037,0.7303823327636271,0.8056475734088059,0.2531241056753229,"['SOCS3', 'IRS1', 'FLNA', 'IRS2']",0.9604056111218777,0,0,4
347,Pancreatic adenocarcinoma pathway WP4263,0.7331272945321016,0.8137870923259051,0.25262875265138235,"['EGF', 'GADD45A', 'PIK3CD', 'PIK3R3', 'VEGFA']",0.9604056111218777,0,0,5
348,Allograft Rejection WP2328,0.7373979004238151,0.7669232649071359,0.23362602459884318,"['VIM', 'VEGFA']",0.9604056111218777,0,0,2
349,Parkinson's disease pathway WP2371,0.7373979004238151,0.7669232649071359,0.23362602459884318,"['GPR37', 'CCNE2']",0.9604056111218777,0,0,2
350,G Protein Signaling Pathways WP35,0.7433286778179341,0.8027258027258027,0.23810209232781548,"['GNA14', 'AKAP10', 'PRKCQ', 'ADCY2', 'PDE8B']",0.9604056111218777,0,0,5
351,Proteoglycan biosynthesis WP4784,0.7467038392679091,0.7431409649952696,0.217061546996512,['XYLT1'],0.9604056111218777,0,0,1
352,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.7524003059572092,0.7428977272727273,0.21134457852250016,"['IFITM3', 'IFITM2']",0.9604056111218777,0,0,2
353,IL-2 signaling pathway WP49,0.7524003059572092,0.7428977272727273,0.21134457852250016,"['SOCS3', 'NMI']",0.9604056111218777,0,0,2
354,Prader-Willi and Angelman Syndrome WP3998,0.7524003059572092,0.7428977272727273,0.21134457852250016,"['BDNF', 'GHRL']",0.9604056111218777,0,0,2
355,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.7524003059572092,0.7428977272727273,0.21134457852250016,"['MAP3K14', 'NFKB2']",0.9604056111218777,0,0,2
356,Non-small cell lung cancer WP4255,0.7526861299625676,0.7791084704638069,0.2213501422927166,"['EGF', 'GADD45A', 'PIK3CD', 'PIK3R3']",0.9604056111218777,0,0,4
357,Retinoblastoma gene in cancer WP2446,0.7632931966849423,0.7664809940625574,0.207036521561621,"['BARD1', 'CCNE2', 'RPA3', 'CDC7']",0.9604056111218777,0,0,4
358,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.7663725240483756,0.6993711391841505,0.1860935009176864,['ETV6'],0.9604056111218777,0,0,1
359,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.7663725240483756,0.6993711391841505,0.1860935009176864,['MRAS'],0.9604056111218777,0,0,1
360,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.7663725240483756,0.6993711391841505,0.1860935009176864,['UGCG'],0.9604056111218777,0,0,1
361,NAD+ biosynthetic pathways WP3645,0.7663725240483756,0.6993711391841505,0.1860935009176864,['CD38'],0.9604056111218777,0,0,1
362,Nucleotide metabolism WP404,0.7663725240483756,0.6993711391841505,0.1860935009176864,['SAT1'],0.9604056111218777,0,0,1
363,Purinergic signaling WP4900,0.7663725240483756,0.6993711391841505,0.1860935009176864,['P2RY12'],0.9604056111218777,0,0,1
364,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.7663725240483756,0.6993711391841505,0.1860935009176864,['HTR2B'],0.9604056111218777,0,0,1
365,Urea cycle and associated pathways WP4595,0.7663725240483756,0.6993711391841505,0.1860935009176864,['PYCR1'],0.9604056111218777,0,0,1
366,G13 Signaling Pathway WP524,0.7666578414161627,0.7203282828282829,0.19140179700249046,"['WAS', 'PIK3CD']",0.9604056111218777,0,0,2
367,Integrated Cancer Pathway WP1971,0.7666578414161627,0.7203282828282829,0.19140179700249046,"['BARD1', 'CHEK2']",0.9604056111218777,0,0,2
368,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.7666578414161627,0.7203282828282829,0.19140179700249046,"['ACTA2', 'TEAD3']",0.9604056111218777,0,0,2
369,IL-6 signaling pathway WP364,0.7801956846124434,0.6990864527629234,0.17352060710993755,"['SOCS3', 'GAB1']",0.9644307314508367,0,0,2
370,ErbB signaling pathway WP673,0.7812526102045495,0.7613168724279835,0.18793619885566873,"['NRG4', 'EGF', 'GAB1', 'PIK3CD', 'PIK3R3']",0.9644307314508367,0,0,5
371,1q21.1 copy number variation syndrome WP4905,0.7845152370803986,0.6604646273520446,0.16028768773935692,['GJA1'],0.9644307314508367,0,0,1
372,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.7845152370803986,0.6604646273520446,0.16028768773935692,['VEGFA'],0.9644307314508367,0,0,1
373,Kallmann's Syndrome WP5074,0.7845152370803986,0.6604646273520446,0.16028768773935692,['PRKCQ'],0.9644307314508367,0,0,1
374,miRNA regulation of p53 pathway in prostate cancer WP3982,0.7845152370803986,0.6604646273520446,0.16028768773935692,['CHEK2'],0.9644307314508367,0,0,1
375,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.7845152370803986,0.6604646273520446,0.16028768773935692,['NFATC2'],0.9644307314508367,0,0,1
376,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.8012502655474676,0.6256535378180551,0.13863352425891065,['BDNF'],0.9706379115345908,0,0,1
377,Glycerolipids and Glycerophospholipids WP4722,0.8012502655474676,0.6256535378180551,0.13863352425891065,['PNPLA3'],0.9706379115345908,0,0,1
378,IL-7 signaling pathway WP205,0.8012502655474676,0.6256535378180551,0.13863352425891065,['IL7'],0.9706379115345908,0,0,1
379,Signal Transduction of S1P Receptor WP26,0.8012502655474676,0.6256535378180551,0.13863352425891065,['S1PR3'],0.9706379115345908,0,0,1
380,Amino Acid metabolism WP3925,0.8021974930470263,0.7197975964579381,0.15864371470684915,"['PNMT', 'ARG2', 'BHMT', 'PYCR1']",0.9706379115345908,0,0,4
381,Corticotropin-releasing hormone signaling pathway WP2355,0.8021974930470263,0.7197975964579381,0.15864371470684915,"['GJA1', 'HSP90AA1', 'IL18', 'PRKCQ']",0.9706379115345908,0,0,4
382,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.8052156541202911,0.6601430976430976,0.14301679653098914,"['HSP90AA1', 'TNFRSF1A']",0.9717393103388852,0,0,2
383,3q29 copy number variation syndrome WP4906,0.810405452215862,0.6853080568720379,0.14406586970939184,"['PIK3R3', 'PIGM', 'SLC51A']",0.9721874641424572,0,0,3
384,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.8166867355414962,0.5943235572374646,0.12035033626727021,['FGFR3'],0.9721874641424572,0,0,1
385,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.8166867355414962,0.5943235572374646,0.12035033626727021,['IRAK2'],0.9721874641424572,0,0,1
386,Sphingolipid Metabolism (general overview) WP4725,0.8166867355414962,0.5943235572374646,0.12035033626727021,['UGCG'],0.9721874641424572,0,0,1
387,Glycogen Synthesis and Degradation WP500,0.8167500957684948,0.6422502047502048,0.130005642393317,"['HKDC1', 'HK2']",0.9721874641424572,0,0,2
388,Pathways affected in adenoid cystic carcinoma WP3651,0.8200136106723387,0.6723240633103819,0.13341218209229264,"['CHEK2', 'ERBIN', 'ARID5B']",0.9721874641424572,0,0,3
389,Chemokine signaling pathway WP3929,0.8266910551589359,0.7266625281291224,0.13830148375112958,"['GRK5', 'WAS', 'PIK3R3', 'PIK3CD', 'CXCR4', 'ADCY2']",0.9721874641424572,0,0,6
390,Interleukin-11 Signaling Pathway WP2332,0.8276690921359896,0.625299043062201,0.11827021884341636,"['SOCS3', 'ICAM1']",0.9721874641424572,0,0,2
391,AMP-activated protein kinase (AMPK) signaling WP1403,0.8292038852538322,0.6598209583991574,0.12357734794465257,"['STRADB', 'PIK3CD', 'PIK3R3']",0.9721874641424572,0,0,3
392,DNA Mismatch Repair WP531,0.830925320788403,0.5659773843312159,0.10482770207346981,['RPA3'],0.9721874641424572,0,0,1
393,Sphingolipid Metabolism (integrated pathway) WP4726,0.830925320788403,0.5659773843312159,0.10482770207346981,['UGCG'],0.9721874641424572,0,0,1
394,Pathways in clear cell renal cell carcinoma WP4018,0.8357517218696187,0.6784494442938466,0.12172990509075193,"['ENPP3', 'HK2', 'PFKP', 'VEGFA']",0.9721874641424572,0,0,4
395,Hepatitis B infection WP4666,0.8379616518896933,0.7285459128315556,0.1287944891350303,"['EGR3', 'SLC10A1', 'IRF7', 'PIK3R3', 'NFATC2', 'PIK3CD', 'TAB2']",0.9721874641424572,0,0,7
396,ATM Signaling Network in Development and Disease  WP3878,0.8379986218975702,0.6092171717171717,0.10767232588984783,"['CHEK2', 'HSPB1']",0.9721874641424572,0,0,2
397,Histone Modifications WP2369,0.8379986218975702,0.6092171717171717,0.10767232588984783,"['SETBP1', 'HIST1H4H']",0.9721874641424572,0,0,2
398,Photodynamic therapy-induced unfolded protein response WP3613,0.844058897017599,0.5402081362346263,0.0915831079183609,['HSPA5'],0.9721874641424572,0,0,1
399,Apoptosis WP254,0.8463805952717012,0.6361543669600541,0.10610173406535292,"['IRF7', 'IGF1R', 'TNFRSF1A']",0.9721874641424572,0,0,3
400,Proteasome Degradation WP183,0.8463805952717012,0.6361543669600541,0.10610173406535292,"['NEDD4', 'UBC', 'PSMB9']",0.9721874641424572,0,0,3
401,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.8477643396643553,0.593939393939394,0.09809062514433149,"['ADCY2', 'SYNE2']",0.9721874641424572,0,0,2
402,Pathogenic Escherichia coli infection WP2272,0.8477643396643553,0.593939393939394,0.09809062514433149,"['TUBA1C', 'WAS']",0.9721874641424572,0,0,2
403,Glycerophospholipid Biosynthetic Pathway WP2533,0.8561731452877546,0.5166796923203488,0.08023139221855431,['PIK3CD'],0.9747337324282959,0,0,1
404,Sphingolipid pathway WP1422,0.8561731452877546,0.5166796923203488,0.08023139221855431,['UGCG'],0.9747337324282959,0,0,1
405,Gastrin signaling pathway WP4659,0.8570449654043322,0.674264007597341,0.10401526524039528,"['IRS1', 'PIK3R3', 'PRKCQ', 'KLF4', 'VEGFA']",0.9747337324282959,0,0,5
406,TGF-beta Signaling Pathway WP366,0.8584422892969373,0.6911107829746391,0.10548826357321246,"['TGFBR3', 'KLF6', 'LIMK2', 'TNC', 'ETS1', 'PML']",0.9747337324282959,0,0,6
407,PPAR signaling pathway WP3942,0.873928209142978,0.5523696264975335,0.07443569986788685,"['DBI', 'ACSBG2']",0.9820348514812087,0,0,2
408,Wnt Signaling Pathway WP363,0.873928209142978,0.5523696264975335,0.07443569986788685,"['GJA1', 'NFATC2']",0.9820348514812087,0,0,2
409,EGF/EGFR signaling pathway WP437,0.8740085789626757,0.702589065255732,0.0946142180391428,"['GJA1', 'PLSCR1', 'EGF', 'INPP5D', 'LIMK2', 'NEDD4', 'GAB1', 'PLCE1']",0.9820348514812087,0,0,8
410,Hippo-Merlin Signaling Dysregulation WP4541,0.8770582426247002,0.6245880355537801,0.08193463123822121,"['FGFR3', 'IGF1R', 'EPHA2', 'TEAD3']",0.9820348514812087,0,0,4
411,GABA receptor Signaling WP4159,0.8776537067467635,0.47526963103122044,0.0620241956395134,['GABRA2'],0.9820348514812087,0,0,1
412,Nanoparticle-mediated activation of receptor signaling WP2643,0.8776537067467635,0.47526963103122044,0.0620241956395134,['PIK3CD'],0.9820348514812087,0,0,1
413,22q11.2 copy number variation syndrome WP4657,0.8829904651111983,0.6164272160477094,0.07670874320215425,"['ACTA2', 'SERPIND1', 'HIST1H4H', 'HES1']",0.983127058073274,0,0,4
414,Intraflagellar transport proteins binding to dynein WP4532,0.887160208586729,0.45695364238410596,0.054710920006867426,['IFT27'],0.983127058073274,0,0,1
415,Melatonin metabolism and effects WP3298,0.887160208586729,0.45695364238410596,0.054710920006867426,['APOE'],0.983127058073274,0,0,1
416,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.887160208586729,0.45695364238410596,0.054710920006867426,['PIK3R3'],0.983127058073274,0,0,1
417,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.8959286707732976,0.4399943936367777,0.04835295407439582,['IFNAR2'],0.9857353633090459,0,0,1
418,Nuclear receptors WP170,0.8959286707732976,0.4399943936367777,0.04835295407439582,['ESRRB'],0.9857353633090459,0,0,1
419,Trans-sulfuration and one-carbon metabolism WP2525,0.8959286707732976,0.4399943936367777,0.04835295407439582,['BHMT'],0.9857353633090459,0,0,1
420,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.9114592703967468,0.5393364928909953,0.05000100714410977,"['SLCO1C1', 'DIO2', 'PRKCQ']",0.9907303157072359,0,0,3
421,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.9183564578119177,0.3959003468937244,0.03371870010037605,['NFATC2'],0.9907303157072359,0,0,1
422,Tumor suppressor activity of SMARCB1 WP4204,0.9183564578119177,0.3959003468937244,0.03371870010037605,['GLI2'],0.9907303157072359,0,0,1
423,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9196603132336354,0.4747727272727273,0.03976264409015762,"['GJA1', 'ACTN1']",0.9907303157072359,0,0,2
424,Joubert Syndrome WP4656,0.9209962828681134,0.5233900195149149,0.043074621089458594,"['FLNA', 'UNC119', 'PDE6B']",0.9907303157072359,0,0,3
425,Ciliopathies WP4803,0.92426201260606,0.6402059202059202,0.050422416041084335,"['ZIC2', 'MAK', 'SCLT1', 'UNC119', 'IFT27', 'PKD1L1', 'CCDC151', 'GLI2']",0.9907303157072359,0,0,8
426,Amyotrophic lateral sclerosis (ALS) WP2447,0.9247025635429021,0.38309884945219275,0.029990183204527048,['TNFRSF1A'],0.9907303157072359,0,0,1
427,p38 MAPK Signaling Pathway WP400,0.9247025635429021,0.38309884945219275,0.029990183204527048,['HSPB1'],0.9907303157072359,0,0,1
428,Acute viral myocarditis WP4298,0.9247494382893793,0.4654263220439691,0.036411444115636404,"['CXCR4', 'NFKB2']",0.9907303157072359,0,0,2
429,AGE/RAGE pathway WP2324,0.9247494382893793,0.4654263220439691,0.036411444115636404,"['LGALS3', 'IRS1']",0.9907303157072359,0,0,2
430,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.9295333489178796,0.4564393939393939,0.03335321057523505,"['ANGPT2', 'TNIP2']",0.9907303157072359,0,0,2
431,Disruption of postsynaptic signaling by CNV WP4875,0.9305558062933474,0.37109744560075686,0.02670908186978494,['GRIN2D'],0.9907303157072359,0,0,1
432,Hepatitis C and Hepatocellular Carcinoma WP3646,0.9305558062933474,0.37109744560075686,0.02670908186978494,['VEGFA'],0.9907303157072359,0,0,1
433,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.9305558062933474,0.37109744560075686,0.02670908186978494,['NFKB2'],0.9907303157072359,0,0,1
434,Pyrimidine metabolism WP4022,0.9335501205418079,0.5011547960750283,0.0344597177259588,"['ENTPD3', 'ENPP3', 'DHODH']",0.9916281234326577,0,0,3
435,Target Of Rapamycin (TOR) Signaling WP1471,0.9359544300719088,0.3598233995584989,0.023816167307255564,['DDIT4L'],0.9918965339382757,0,0,1
436,Fas ligand pathway and stress induction of heat shock proteins WP314,0.9409337140403152,0.3492125326951973,0.021260961327019403,['HSPB1'],0.9948863352582232,0,0,1
437,Nonalcoholic fatty liver disease WP4396,0.9439592529065765,0.573101925671532,0.03305209361526627,"['SOCS3', 'IRS1', 'PIK3R3', 'PIK3CD', 'IRS2', 'TNFRSF1A']",0.9958014086726127,0,0,6
438,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.9494325106393092,0.41623471557682085,0.021598764906986118,"['ADCY2', 'IGF1R']",0.9992885557185422,0,0,2
439,Common Pathways Underlying Drug Addiction WP2636,0.9536685434088741,0.3208212943312281,0.015219475606818546,['GRIA4'],0.999702035708045,0,0,1
440,Metabolic reprogramming in colon cancer WP4290,0.9572716341521351,0.31235373201214955,0.013639890432954967,['PYCR1'],0.999702035708045,0,0,1
441,Splicing factor NOVA regulated synaptic proteins WP4148,0.9572716341521351,0.31235373201214955,0.013639890432954967,['AGRN'],0.999702035708045,0,0,1
442,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.9638981347243828,0.38251466275659823,0.014064933837540174,"['GADD45A', 'NTN1']",0.999702035708045,0,0,2
443,16p11.2 proximal deletion syndrome WP4949,0.9684911412990244,0.3705018939393939,0.011861967518835108,"['MVP', 'TBX6']",0.999702035708045,0,0,2
444,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.969093312176644,0.28251565526873,0.008869402236086153,['CP'],0.999702035708045,0,0,1
445,Circadian rhythm related genes WP3594,0.9700495582839832,0.5181787904859704,0.015756841689808752,"['CLDN4', 'EGR3', 'ID2', 'UBC', 'GHRL', 'PML']",0.999702035708045,0,0,6
446,Leptin signaling pathway WP2034,0.9705712280037329,0.36477272727272725,0.010895938630788846,"['SOCS3', 'IRS1']",0.999702035708045,0,0,2
447,Nucleotide Excision Repair WP4753,0.9714976734965702,0.2759235220347187,0.007978716290501958,['RPA3'],0.999702035708045,0,0,1
448,7q11.23 copy number variation syndrome WP4932,0.9729319028239568,0.41324809875454643,0.011340017969142602,"['CLDN4', 'FZD9', 'HSPA2']",0.999702035708045,0,0,3
449,DNA IR-double strand breaks and cellular response via ATM WP3959,0.9776463059869256,0.25786680926329647,0.005829678680871845,['CHEK2'],0.999702035708045,0,0,1
450,Rett syndrome causing genes WP4312,0.9793857503052471,0.25236015217697616,0.0052565835444919615,['SYNE2'],0.999702035708045,0,0,1
451,Kit receptor signaling pathway WP304,0.982469390301823,0.24202112254551775,0.004280407508472133,['INPP5D'],0.999702035708045,0,0,1
452,Endoderm differentiation WP2853,0.9854983557125387,0.3699052132701422,0.005403509094766438,"['TRIM5', 'SESN1', 'GLI2']",0.999702035708045,0,0,3
453,Genes related to primary cilium development (based on CRISPR) WP4536,0.9863886367783039,0.36606244197977234,0.005016829792939804,"['SCLT1', 'IFT27', 'CEP76']",0.999702035708045,0,0,3
454,Androgen receptor signaling pathway WP138,0.9871864347723653,0.30762987012987014,0.003967307717451962,"['LIMK2', 'FLNA']",0.999702035708045,0,0,2
455,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9948029325656996,0.1850756859035005,0.0009643589154779361,['DBI'],0.999702035708045,0,0,1
456,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9980915576616959,0.27891928200918015,0.000532809947155489,"['IRS1', 'BDNF', 'IRS2']",0.999702035708045,0,0,3
457,Integrin-mediated Cell Adhesion WP185,0.9983299731316463,0.15168716493219805,0.00025353340379377957,['SELENOP'],0.999702035708045,0,0,1
458,DNA Repair Pathways Full Network WP4946,0.9986121302942247,0.21878507295173963,0.0003038560799570982,"['RPA3', 'FANCA']",0.999702035708045,0,0,2
459,Fragile X Syndrome  WP4549,0.9991050380440818,0.20717038809144073,0.00018549263254577568,"['BDNF', 'GAB1']",0.999702035708045,0,0,2
460,Thermogenesis WP4321,0.9994173481739943,0.12988241654277605,7.569828217799777e-05,['ADCY2'],0.999702035708045,0,0,1
461,Ciliary landscape WP4352,0.999702035708045,0.29551842784673604,8.806706018430645e-05,"['CDH23', 'IFT27', 'STOM', 'VIM', 'MAPRE2']",0.999702035708045,0,0,5
